美股异动丨Tempus AI涨超7%，推出新型HRD-RNA癌症检测算法

Core Viewpoint - Tempus AI has launched a new HRD-RNA cancer detection algorithm, which offers real-time assessment of tumor functional status by analyzing gene expression rather than structural DNA damage, marking a significant advancement over traditional DNA testing methods [1] Company Summary - Tempus AI's stock rose over 7%, reaching $56.31 following the announcement of the new HRD-RNA cancer detection algorithm [1] - The new RNA-based approach allows for the detection of HRD in patients and cancer types where genomic scars are difficult to identify [1]